We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.14B
AUM Growth
+$78M
Cap. Flow
+$4.03M
Cap. Flow %
0.35%
Top 10 Hldgs %
49.37%
Holding
304
New
70
Increased
124
Reduced
70
Closed
7

Top Buys

Rank Stock Value
1
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$3.94M
2
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$3.93M
3
NMRA icon
Neumora Therapeutics
NMRA
+$3.31M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2.97M
5
MSFT icon
Microsoft
MSFT
+$2.45M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$5.85M
3
JMST icon
JPMorgan Ultra-Short Municipal Income ETF
JMST
+$3.04M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2.44M
5
EW icon
Edwards Lifesciences
EW
+$2.12M

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.4%
2 Technology 5.18%
3 Healthcare 2.32%
4 Financials 1.59%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHG icon
151
Schwab US Large-Cap Growth ETF
SCHG
$63.1B
$456K 0.04%
19,680
+208
+1% +$4.6K
SPGI icon
152
S&P Global
SPGI
$131B
$451K 0.04%
1,060
+18
+2% +$7.8K
TGT icon
153
Target
TGT
$74.1B
$446K 0.04%
2,514
+497
+25% +$75.6K
MCD icon
154
McDonald's
MCD
$188B
$444K 0.04%
1,576
+176
+13% +$51.2K
IWR icon
155
iShares Russell Mid-Cap ETF
IWR
$57.1B
$444K 0.04%
5,283
+6
+0.1% +$475
UBS icon
156
UBS Group
UBS
$168B
$438K 0.04%
+14,255
New +$421K
BUD icon
157
AB InBev
BUD
$158B
$428K 0.04%
7,039
+3,344
+91% +$209K
HON icon
158
Honeywell
HON
$68.9B
$428K 0.04%
2,211
+280
+15% +$52.7K
TMUS icon
159
T-Mobile US
TMUS
$195B
$427K 0.04%
2,617
-4
-0.2% -$651
ZTS icon
160
Zoetis
ZTS
$32B
$425K 0.04%
2,510
+68
+3% +$12.7K
PFE icon
161
Pfizer
PFE
$159B
$424K 0.04%
15,294
+3,718
+32% +$103K
MT icon
162
ArcelorMittal
MT
$56.1B
$423K 0.04%
+15,350
New +$414K
OSK icon
163
Oshkosh
OSK
$9.51B
$421K 0.04%
3,377
– –
PANW icon
164
Palo Alto Networks
PANW
$303B
$415K 0.04%
2,924
+478
+20% +$75.4K
SPYG icon
165
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.6B
$413K 0.04%
5,648
– –
PPBI
166
DELISTED
Pacific Premier Bancorp
PPBI
$408K 0.04%
17,004
+223
+1% +$5.58K
RTX icon
167
RTX Corp
RTX
$285B
$401K 0.04%
4,112
+316
+8% +$28.5K
TXN icon
168
Texas Instruments
TXN
$236B
$398K 0.04%
2,284
+185
+9% +$30.9K
FUTY icon
169
Fidelity MSCI Utilities Index ETF
FUTY
$2.24B
$381K 0.03%
8,974
– –
CVX icon
170
Chevron
CVX
$396B
$380K 0.03%
+2,412
New +$364K
SONY icon
171
Sony
SONY
$145B
$380K 0.03%
22,170
+8,350
+60% +$153K
SHOP icon
172
Shopify
SHOP
$197B
$378K 0.03%
4,901
+17
+0.3% +$1.34K
ORLY icon
173
O'Reilly Automotive
ORLY
$71.6B
$376K 0.03%
4,995
-11,295
-69% -$790K
MUFG icon
174
Mitsubishi UFJ Financial
MUFG
$258B
$372K 0.03%
36,381
+13,686
+60% +$132K
ADI icon
175
Analog Devices
ADI
$175B
$369K 0.03%
1,868
+65
+4% +$12.5K
5 6
7
8 9

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Callan Capital held 304 positions worth $1.14B, up 7.4% from $1.06B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Callan Capital's Q1 2024 filing shows 70 new, 124 increased, 70 reduced and 7 closed positions. Its largest new stake was Neumora Therapeutics: 204,987 shares worth $2.82M. The largest sale was NVIDIA, an estimated $16M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 88% a quarter earlier, followed by Technology and Healthcare.

  • Callan Capital's largest Q1 2024 buy was Neumora Therapeutics: 204,987 shares worth $2.82M.
  • Callan Capital added most to Avantis US Small Cap Value ETF in Q1 2024, an estimated $3.94M increase.
  • Callan Capital's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $16M.
  • Callan Capital fully exited Edwards Lifesciences in Q1 2024, selling an estimated $2.12M.
  • Callan Capital's ten largest holdings make up 49% of its $1.14B portfolio in Q1 2024.
  • Callan Capital opened 70 new positions and closed 7 in Q1 2024.
  • Callan Capital's portfolio value rose 7.4% quarter-over-quarter to $1.14B.

Based on Callan Capital's 13F filing for Q1 2024, filed 3 May 2024.